thrombocytopenia Archives -

Shares in US biotech CTI BioPharma have shot up after the FDA agreed to an accelerated review early

CTI wins over FDA to claim early review of myelofibrosis drug

https://pharmaphorum.com/news/cti-wins-over-fda-to-claim-early-review-of-myelofibrosis-drug/

Sweden’s Sobi has added another already-marketed product to its rare disease portfolio via a $29 per share takeover

Sobi stays on its acquisitive streak with $915m Dova deal

https://pharmaphorum.com/news/sobi-stays-on-its-acquisitive-streak-with-915m-dova-deal/

The US drug regulator has approved Mulpleta (lusutrombopag) as a treatment for thrombocytopenia in certain patients with chronic

Shionogi’s Mulpleta gets FDA green light for patients with liver disease

https://pharmaphorum.com/news/shionogis-mulpleta-gets-fda-green-light-for-patients-with-liver-disease/

thrombocytopenia